Gail D'Onofrio, E Jennifer Edelman, Kathryn F Hawk, Marek C Chawarski, Michael V Pantalon, Patricia H Owens, Shara H Martel, Richard Rothman, Mustapha Saheed, Robert P Schwartz, Ethan Cowan, Lynne Richardson, Edwin Salsitz, Michael S Lyons, Caroline Freiermuth, Christine Wilder, Lauren Whiteside, Judith I Tsui, Jared W Klein, Edouard Coupet, Patrick G O'Connor, Abigail G Matthews, Sean M Murphy, Kristen Huntley, David A Fiellin
IMPORTANCE: Emergency department (ED)-initiated buprenorphine for the treatment of opioid use disorder (OUD) is underused. OBJECTIVE: To evaluate whether provision of ED-initiated buprenorphine with referral for OUD increased after implementation facilitation (IF), an educational and implementation strategy. DESIGN, SETTING, AND PARTICIPANTS: This multisite hybrid type 3 effectiveness-implementation nonrandomized trial compared grand rounds with IF, with pre-post 12-month baseline and IF evaluation periods, at 4 academic EDs...
April 3, 2023: JAMA Network Open